I believe the time has come for the Nobel Prize committee to consider rescinding Paul Krugman’s award. His columns in the New York Times are supposed to give us insights into public policy issues based on economics.
You probably saw the headlines. Daraprim is a small, white tablet that looks a lot like Aspirin. It was created 62 year ago and treats a parasitic infection called toxoplasmosis.
Until we entered the Great Recession, most economists regarded Keynesian economics as a relic of the past. You could still find it discussed in some introductory textbooks.
What we call the Reagan Revolution was not just a US phenomenon. Beginning in the last quarter of the 20th century there was massive political change all over the world.
As Americans celebrated the Labor Day weekend, nearly 94 million people of working age actually had nothing to celebrate. That’s because they aren’t in the labor force.
In every field of endeavor, change is brought about by entrepreneurs. These are the creators. The innovators. They rarely stop thinking. The only question is: What are they thinking about?
In a recent NY Times column, political economist, Paul Krugman, writes, “Social Security does not face a financial crisis; its long-term funding shortfall could easily be closed with modest increases in revenue.”
One of the strangest things about Obamacare is that it is trying to force millions of families to obtain the wrong kind of insurance. When they turn it down, these families often end up with no insurance at all.
It’s been five years since the passage of the Affordable Care Act (Obamacare). In all that time Republicans have not produced a single, credible alternative to it that they can unite behind. Have you ever wondered why?
Big business is against it. So is big labor. Ditto for K Street. What do they want? The repeal of Obamacare’s tax on high cost health care plans.